Evaluation of Oral Care to Prevent Oral Mucositis in ER Positive MBC Patients Treated With Everolimus: Phase 3 RCT
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: PROCEDURE: Oral management|DRUG: Everolimus
Sponsor: Comprehensive Support Project for Oncology Research
Collaborators: Novartis Pharmaceuticals